Clinical Trial: Phase 1b FORTRESS Study
Commitment to Patients
This study is evaluating clinical response rates to NG-350A in combination with chemoradiotherapy (CRT) in adult patients with mismatch-repair proficient (pMMR) locally advanced rectal cancer (LARC) and at least one risk factor for local or distant recurrence.
FORTRESS Study Fact Sheets
Resources
Akamis Bio is partnering with colorectal cancer advocacy organizations to provide patients and their families with critical resources and support. These groups offer disease education, tools to navigate treatment options, information about clinical studies, opportunities to connect with the CRC community, and much more. Following are links to several leading CRC-focused advocacy organizations:
